Teplensky, Michelle H. http://orcid.org/0000-0003-4664-420X
Evangelopoulos, Michael http://orcid.org/0000-0002-5300-4289
Dittmar, Jasper W.
Forsyth, Connor M.
Sinegra, Andrew J.
Wang, Shuya
Mirkin, Chad A. http://orcid.org/0000-0002-6634-7627
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (T32CA186897, R01CA208783, P50CA221747)
Alexander S. Onassis Public Benefit Foundation
Dr. John H. Nicholson Fellowship
National Science Foundation (ECCS-2025633)
Polsky Urological Cancer Institute, Edward Bachrach, State of Illinois, International Institute for Nanotechnology
Article History
Received: 2 September 2021
Accepted: 19 December 2022
First Online: 30 January 2023
Competing interests
: C.A.M. and M.H.T. have financial interests in Flashpoint Therapeutics Inc., which could potentially benefit from the outcomes of this research.
Free to read: This content has been made available to all.